Prescribed by oncologists/hematologists for: 🔹 Multiple Myeloma (MM): As maintenance therapy after stem cell transplant or in combination with dexamethasone for newly diagnosed/relapsed patients. 🔹 Myelodysplastic Syndromes (MDS): For transfusion-dependent anemia due to specific genetic abnormalities (deletion 5q). 🔹 Mantle Cell Lymphoma (MCL): For patients whose disease has relapsed or progressed after prior therapies.

Dosage and administration

Sales Unit: Box of 21 capsules (3 strips of 7), 25 mg strength. ⚠️ APPLICATION INSTRUCTIONS: How to Take: Swallow the capsule whole with water. Do not break, chew, or open the capsules. Take at the same time daily. Standard Cycle: Typically taken for 21 consecutive days followed by a 7-day break (28-day cycle). Handling: Females who are pregnant or may become pregnant should not handle the capsules or blisters due to risk of absorption through skin. ✋ Doctor's Orders: Strictly follow the dosage schedule prescribed by your healthcare provider based on your blood counts.

⛔ Pregnancy & Breastfeeding: STRICTLY CONTRAINDICATED. Causes severe life-threatening birth defects. Women of childbearing potential (unless strict contraception program is followed). Children and adolescents under 18 years. Severe renal impairment (requires dose adjustment). Hypersensitivity to Lenalidomide.

Treatment requires careful monitoring. Potential side effects include: 📉 Hematologic: Neutropenia (low white blood cells), thrombocytopenia (low platelets), and anemia. 🩸 Thrombosis: Increased risk of blood clots (DVT/PE). Prophylactic blood thinners are often prescribed. 🤢 General: Fatigue, diarrhea, constipation, muscle cramps, and skin rash.

Revlixen 25 — Lenalidomide 25 mg, 21 product-page.units_short, Everest

100% original product

Active ingredient

Lenalidomide

Manufacturer

Everest

Dosage 25 mg

Dosage form Capsules

Capsules per pack 21

Revlixen 25 Capsules — Lenalidomide 25 mg (21 Caps) Everest

Name: Revlixen 25
Brand: Everest
SKU: PROD-193
Price: 3950 UAH
Availability: InStock

3950₴ ~~4828₴~~ -18%

Revlixen 25 (Lenalidomide) is a potent immunomodulatory drug and a generic equivalent to Revlimid. It functions by altering the immune system's response to slow down or stop the growth of cancer cells.

Manufacturer: Everest Pharmaceuticals (Bangladesh). Lenalidomide inhibits the growth of new blood vessels (angiogenesis) in tumors and enhances the immune system's ability to target abnormal cells.

Key Features:

✅ Dual Mechanism: Direct anti-tumor activity combined with anti-angiogenic properties (starving the tumor of blood supply).
✅ Immune Boosting: Stimulates T-cells and Natural Killer (NK) cells to attack cancer cells.
✅ High Potency: Considered a standard of care for Multiple Myeloma and certain blood disorders.

Prescribed by oncologists/hematologists for:

🔹 Multiple Myeloma (MM): As maintenance therapy after stem cell transplant or in combination with dexamethasone for newly diagnosed/relapsed patients.
🔹 Myelodysplastic Syndromes (MDS): For transfusion-dependent anemia due to specific genetic abnormalities (deletion 5q).
🔹 Mantle Cell Lymphoma (MCL): For patients whose disease has relapsed or progressed after prior therapies.

Sales Unit: Box of 21 capsules (3 strips of 7), 25 mg strength.

⚠️ APPLICATION INSTRUCTIONS:

How to Take: Swallow the capsule whole with water. Do not break, chew, or open the capsules. Take at the same time daily.
Standard Cycle: Typically taken for 21 consecutive days followed by a 7-day break (28-day cycle).
Handling: Females who are pregnant or may become pregnant should not handle the capsules or blisters due to risk of absorption through skin.
✋ Doctor's Orders: Strictly follow the dosage schedule prescribed by your healthcare provider based on your blood counts.

⛔ Pregnancy & Breastfeeding: STRICTLY CONTRAINDICATED. Causes severe life-threatening birth defects.
Women of childbearing potential (unless strict contraception program is followed).
Children and adolescents under 18 years.
Severe renal impairment (requires dose adjustment).
Hypersensitivity to Lenalidomide.

Treatment requires careful monitoring. Potential side effects include:

📉 Hematologic: Neutropenia (low white blood cells), thrombocytopenia (low platelets), and anemia.
🩸 Thrombosis: Increased risk of blood clots (DVT/PE). Prophylactic blood thinners are often prescribed.
🤢 General: Fatigue, diarrhea, constipation, muscle cramps, and skin rash.